GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » Net Change in Cash

MediClin AG (XTER:MED) Net Change in Cash : €23.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is MediClin AG Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

MediClin AG's Net Change in Cash for the three months ended in Dec. 2023 was €4.8 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was €23.0 Mil.

MediClin AG Net Change in Cash Historical Data

The historical data trend for MediClin AG's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediClin AG Net Change in Cash Chart

MediClin AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.42 63.59 19.62 -27.78 23.01

MediClin AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.92 1.09 -3.23 20.36 4.80

MediClin AG Net Change in Cash Calculation

MediClin AG's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=78.001+-9.511+-45.479+0
=23.0

MediClin AG's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=28.143+-12.013+-11.335+0
=4.8

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €23.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediClin AG Net Change in Cash Related Terms

Thank you for viewing the detailed overview of MediClin AG's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

MediClin AG (XTER:MED) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » Net Change in Cash
Comparable Companies
XTER:V3V XTER:M12 FRA:EIF HCA SAU:4013 SZSE:300015 XTER:FRE BKK:BDMS ADX:PUREHEALTH XTER:FME DVA XKLS:5225 HKSE:06618 BSP:RDOR3 UHS NSE:APOLLOHOSP THC BOM:543220 CHE EHC
Traded in Other Exchanges
MED:Germany MED:Germany
Address
Okenstrasse 27, Offenburg, DEU, 77652
Website
https://www.mediclin.de
MediClin AG is a company engaged in operating hospitals. It is focused on providing services in the areas of neurosciences and psychological sciences as well as orthopedics in Germany. The hospitals are acute-care hospitals providing basic, standard, and specialized care, as well as specialist clinics for medical rehabilitation. The operating segments of the group are Post-acute, Acute and Other activities. It generates majority of the revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.

MediClin AG (XTER:MED) Headlines

From GuruFocus

OPTAVIA ACTIVE� Now Available

By PRNewswire • 09-13-2023

Medifast, Inc. Announces Quarterly Dividend

By PRNewswire PRNewswire • 07-06-2022

Medifast to Announce Financial Results for the First Quarter Ended March 31, 2023

By PRNewswire PRNewswire • 04-17-2023

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022

By PRNewswire PRNewswire • 02-07-2023

Medifast Announces Quarterly Dividend

By PRNewswire • 09-07-2023

Medifast's OPTAVIA Program Named #1 Weight Loss Program in the U.S. by Revenue for 2021*

By PRNewswire PRNewswire • 11-02-2022

Health is Top Priority for Majority of U.S. Adults Despite Continuous Cycle of Failed Diets

By PRNewswire PRNewswire • 07-11-2022

Medifast Announces First Quarter 2023 Financial Results

By PRNewswire PRNewswire • 05-01-2023

Medifast, Inc. Announces $100M Accelerated Share Repurchase Program

By PRNewswire PRNewswire • 07-11-2022

Medifast Announces Quarterly Dividend

By PRNewswire PRNewswire • 03-17-2023